BAY I 4160
Alternative Names: BAYI 4160Latest Information Update: 23 Sep 2010
At a glance
- Originator Bayer
- Class
- Mechanism of Action Chloride channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Asthma in Germany (Unknown route)
- 06 Jun 2001 No-Development-Reported for Chronic obstructive pulmonary disease in Germany (Unknown route)
- 11 Jan 1999 New profile